The relative role of soluble guanylyl cylase dependent and independent pathways in nitric oxide inhibition of platelet aggregation under flow

Cellular and Molecular Bioengineering

Volumn 7, Issue 3, 2014, Pages 421-431

  Sylman, J L ^a   Lantvit, S M ^b   Reynolds, M M ^b,c   Neeves, Keith B ^a,d  

^a Department of Metallurgical and Materials Engineering   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c Department of Mechanical Engineering   (United States)

^d University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

Biotransport; Nitric oxide; Platelets; Soluble guanylyl cyclase

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM ION; HYDROLASE; NITRIC OXIDE; SOLUBLE GUANYLYL CYLASE; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD FLOW; BLOOD VESSEL INJURY; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SHEAR RATE; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE VOLUME;

EID: 84906939338     PISSN: 18655025     EISSN: 18655033     Source Type: Journal    
DOI: 10.1007/s12195-014-0331-1     Document Type: Article

References (37)

1. Antl, M., et al. IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 109:552-559, 2007. (Pubitemid 46105953)
2. Ballou, D. P., Y. Zhao, P. E. Brandish, and M. A. Marletta. Revisiting the kinetics of nitric oxide (NO) binding to soluble guanylate cyclase: the simple NO-binding model is incorrect. Proc. Natl. Acad. Sci. USA 99:12097-12101, 2002.
3. Batchelor, M. M., et al. More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J. Med. Chem. 46:5153-5161, 2003. (Pubitemid 37414185)
4. Bolte, S., and F. P. Cordelières. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224:213-232, 2006.
5. Chatterjee, M. S., J. E. Purvis, L. F. Brass, and S. L. Diamond. Pairwise agonist scanning predicts cellular signaling responses to combinatorial stimuli. Nat. Biotechnol. 28:727-732, 2010.
6. Condorelli, P., and S. C. George. In vivo control of soluble guanylate cyclase activation by nitric oxide: a kinetic analysis. Biophys. J. 80:2110-2119, 2001. (Pubitemid 32401977)
7. Dangel, O., E. Mergia, K. Karlisch, D. Groneberg, D. Koesling, and A. Friebe. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition. J. Thromb. Haemost. 8:1343-1352, 2010.
8. 2+ influx in platelets: activation by thrombin and by the depletion of the stores. Effect of cyclic nucleotides. Biochem. J. 303:599-605, 1994.
9. Folie, B. J., and L. V. McIntire. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow. Biophys. J. 56:1121-1141, 2005.
10. Garthwaite, J., E. Southam, C. L. Boulton, E. B. Nielsen, K. Schmidt, and B. Mayer. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:184-188, 1995.
11. Hansen, R. R., A. A. Tipnis, T. C. White-Adams, J. A. Di Paola, and K. B. Neeves. Characterization of collagen thin films for von Willebrand factor binding and platelet adhesion. Langmuir 27:13648-13658, 2011.
12. Hansen, R. R., A. R. Wufsus, S. T. Barton, A. A. Onasoga, R. M. Johnson-Paben, and K. B. Neeves. High content evaluation of shear dependent platelet function in a Microfluidic flow assay. Ann. Biomed. Eng. 41:250-263, 2012.
13. Heemskerk, J., K. S. Sakariassen, J. J. Zwaginga, L. F. Brass, S. P. Jackson, and R. W. Farndale. Collagen surfaces to measure thrombus formation under flow: possibilities for standardization. J. Thromb. Haemost. 9:856-858, 2011.
14. Homer, K. L., and J. C. Wanstall. Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor. Br. J. Pharmacol. 131:673-682, 2000.
15. Homer, K. L., and J. C. Wanstall. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate. Br. J. Pharmacol. 137:1071-1081, 2002. (Pubitemid 35440748)
16. Kibbe, M. Inducible nitric oxide synthase and vascular injury. Cardiovasc. Res. 43:650-657, 1999. (Pubitemid 29369263)
17. Lies, B., D. Groneberg, S. Gambaryan, and A. Friebe. Lack of effect of ODQ does not exclude cGMP signalling via NO-sensitive guanylyl cyclase. Br. J. Pharmacol. 170:317-327, 2013.
18. Marcondes, S., et al. Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for a-actinin nitration. Proc. Natl. Acad. Sci. USA 103:3434-3439, 2006. (Pubitemid 43346486)
19. Marjanovic, J. A., Z. Li, A. Stojanovic, and X. Du. Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation. J. Biol. Chem. 280:37430-37438, 2005. (Pubitemid 41642350)
20. Morrell, C. N. Regulation of platelet granule exocytosis by S-nitrosylation. Proc. Natl. Acad. Sci. USA 102:3782-3787, 2005. (Pubitemid 40354689)
21. Naseem, K. M., and W. Roberts. Nitric oxide at a glance. Platelets 22:148-152, 2011.
22. Neeves, K. B., O. J. T. McCarty, A. J. Reininger, M. Sugimoto, M. R. King, and The Biorheology Subcommittee of the SSC of the ISTH. Flow-dependent thrombin and fibrin generation in vitro: opportunities for standardization: communication from SSC of the ISTH. J. Thromb. Haemost. 12:418-420, 2014.
23. Onasoga-Jarvis, A. A., T. J. Puls, S. K. O'Brien, L. Kuang, H. J. Liang, and K. B. Neeves. Thrombin generation and fibrin formation under flow on biomimetic tissue factor rich surfaces. J. Thromb. Haemost. 12:373-382, 2014.
24. Plata, A. M., S. J. Sherwin, and R. Krams. Endothelial nitric oxide production and transport in flow chambers: the importance of convection. Ann. Biomed. Eng. 38:2805-2816, 2010.
25. Pugh, N., A. M. C. Simpson, P. A. Smethurst, P. G. de Groot, N. Raynal, and R. W. Farndale. Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood. Blood 115:5069-5079, 2010.
26. Roberts, W., R. Riba, S. Homer-Vanniasinkam, R. W. Farndale, and K. M. Naseem. Nitric oxide specifically inhibits integrin-mediated platelet adhesion and spreading on collagen. J. Thromb. Haemost. 6:2175-2185, 2008.
27. Roest, M., A. Reininger, J. J. Zwaginga, M. R. King, and J. W. M. Heemskerk. Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization. J. Thromb. Haemost. 9:2322-2324, 2011.
28. Ruggeri, Z. M., and G. L. Mendolicchio. Adhesion mechanisms in platelet function. Circ. Res. 100:1673-1685, 2007. (Pubitemid 46987859)
29. Schrammel, A., S. Behrends, K. Schmidt, D. Koesling, and B. Mayer. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 50:1-5, 1996. (Pubitemid 26250067)
30. Sylman, J. L., S. M. Lantvit, M. C. VeDepo, M. M. Reynolds, and K. B. Neeves. Transport limitations of nitric oxide inhibition of platelet aggregation under flow. Ann. Biomed. Eng. 274:2193-2205, 2013.
31. 2+ stores. Circ. Res. 84:201-209, 1999.
32. Tsai, M., et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J. Clin. Investig. 122:408-418, 2012.
33. van Gestel, M. A. In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability. Arterioscler. Thromb. Vasc. Biol. 23:518-523, 2003.
34. Van Kruchten, R., J. M. Cosemans, and J. W. Heemskerk. Measurement of whole blood thrombus formation using parallel-plate flow chambers - a practical guide. Platelets 23:229-242, 2012.
35. Vaughn, M. W., L. Kuo, and J. C. Liao. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am. J. Physiol. Heart Circ. Physiol. 274:H2163-H2176, 1998.
36. Wanstall, J. C., K. L. Homer, and S. A. Doggrell. Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Curr. Vasc. Pharmacol. 3:41-53, 2005. (Pubitemid 40089526)
37. Zhang, G., et al. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood 118:3670-3679, 2011.